Drug Discovery unbound™

Propelled by a groundbreaking biochemistry platform, we are charting towards a blue ocean of opportunities to develop novel medicines that act on transporters — a superfamliy of over 400 membrane proteins, which precisely control molecular trafficking across biological boundaries.




We will share with the public our exciting science and breakthrough technology after launching first clinical program as early as in 2022.